Our latest annual report is dedicated to our fantastic supporters who inspire us in everything we do. Its pages may be full of financial tables and figures, but the story they tell is one of commitment and dedication to every single person we support. During our last financial year, we were able to reach more people than ever before, fund more life-saving research, and provide far more direct support for women with ovarian cancer and their families.
Our work on early diagnosis
Earlier diagnosis saves lives. We aim to raise public awareness of ovarian cancer symptoms and in 2016-17 we did just that – now 42 per cent of GPs in the UK are able to spot ovarian cancer earlier after completing our education modules, and over 60 million people have learned the symptoms of ovarian cancer through our public symptoms awareness programme.
Finding new treatments and fundraising
We are dedicated to funding innovative research across the UK and thanks to your support, Target Ovarian Cancer’s total research spend rose to over £850,000 during 2016-17. While survival rates for ovarian cancer are improving, progress remains frustratingly slow, the UK’s spend on ovarian cancer research has been in decline over the last few years. To combat this trend, this year we launched our next grant round which has awarded £200,000 and are now proud to have committed over £1 million to ovarian cancer research.
Thanks to the tireless efforts of our hundreds of supporters, we were able to raise an incredible £1.8m. For an in-depth view of our financial statements, download our full Annual Report.
Supporting women with ovarian cancer
We empower women to live well with ovarian cancer by providing emotional support to women and their families. Being diagnosed with ovarian cancer is often very isolating, however 97 per cent of the women who attended our free support events in 2016-17 said they felt less isolated as a result. With this year’s launch of the Target Ovarian Cancer Support Line, we were there for more women than ever before. Our Support Line puts women with ovarian cancer and their families in direct contact with our new Nurse Advisers and we saw a 48 per cent increase in the number of people contacting us over the course of the year.
Target Ovarian Cancer Chief Executive Annwen Jones is thankful for the success of this past year and eager to carry that success into years to come: “We have now reached a pivotal moment: during the year we carried out a comprehensive review of our work, and defined a bold new strategy, with the goal of doubling long-term ovarian cancer survival by 2050.
“Target Ovarian Cancer is proud of the success and achievements of the year, and profoundly grateful to all of our supporters for everything they do.”